Cargando…
Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo
Bmi1 gene overexpression is found in various human tumors and has been shown as a potential target for gene treatment. However, siRNA-based treatments targeting Bmi1 gene have been restricted to limited delivery, low bioavailability and hence relatively reduced efficacy. To overcome these barriers,...
Autores principales: | Yang, Tan, Li, Bin, Qi, Shibo, Liu, Yong, Gai, Yongkang, Ye, Peng, Yang, Guang, Zhang, Wendian, Zhang, Peng, He, Xingxing, Li, Weijie, Zhang, Zhiping, Xiang, Guangya, Xu, Chuanrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173760/ https://www.ncbi.nlm.nih.gov/pubmed/25285163 http://dx.doi.org/10.7150/thno.9423 |
Ejemplares similares
-
A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo
por: Huang, Yifei, et al.
Publicado: (2014) -
Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting
por: Ye, Peng, et al.
Publicado: (2014) -
Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid in vitro and in vivo
por: Li, Weijie, et al.
Publicado: (2019) -
Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate
por: Yang, Tan, et al.
Publicado: (2017) -
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
por: Zhang, Wendian, et al.
Publicado: (2015)